Agios Pharma (AGIO) Tops Q2 EPS by 5c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.51), $0.05 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $6.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• Lennar Corp. (LEN) Misses Q2 EPS by 1c